Capstone Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-91,010
Closed -$16.1M 1393
2020
Q1
$16.1M Sell
91,010
-7,368
-7% -$1.39M 0.26% 66
2019
Q4
$18.8M Sell
98,378
-529,680
-84% -$95.6M 0.1% 215
2019
Q3
$106M Buy
628,058
+359,684
+134% +$58.6M 0.73% 24
2019
Q2
$44.9M Buy
268,374
+261,231
+3,657% +$36.2M 0.33% 68
2019
Q1
$1.05M Buy
7,143
+2,874
+67% +$417K 0.01% 795
2018
Q4
$571K Buy
4,269
+4,107
+2,535% +$673K 0.01% 785
2018
Q3
$31K Sell
162
-4,177
-96% -$767K ﹤0.01% 1233
2018
Q2
$723K Sell
4,339
-1,602
-27% -$257K 0.01% 437
2018
Q1
$1M Buy
+5,941
New +$997K 0.02% 237
2017
Q2
Sell
-5,800
Closed -$1.39M 1029
2017
Q1
$1.39M Sell
5,800
-8,346
-59% -$1.94M 0.03% 361
2016
Q4
$2.97M Buy
14,146
+11,871
+522% +$2.46M 0.09% 204
2016
Q3
$523K Buy
2,275
+800
+54% +$195K 0.01% 511
2016
Q2
$340K Sell
1,475
-165,800
-99% -$38.2M 0.01% 546
2016
Q1
$44.8M Buy
167,275
+154,775
+1,238% +$44.3M 1.37% 17
2015
Q4
$3.91M Buy
+12,500
New +$3.72M 0.1% 132
2013
Q3
Sell
-38,501
Closed -$5.13M 591
2013
Q2
$4.86M Buy
+38,501
New +$4.36M 0.05% 144

Other funds holding AGN

Capstone Investment Advisors's AGN Position: Q2 2020 in Review

Capstone Investment Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 91,010 shares — an estimated $16.1M sold.

Capstone Investment Advisors first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $106M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Capstone Investment Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Capstone Investment Advisors sold 91,010 Allergan plc shares in Q2 2020, an estimated $16.1M.
  • Capstone Investment Advisors first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
  • Capstone Investment Advisors's Allergan plc position peaked at $106M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Capstone Investment Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.